Palisade Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$22.8M |
| 2 |
BioLife Solutions
BLFS
|
+$15M |
| 3 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
+$14.6M |
| 4 |
PING
Ping Identity Holding Corp.
PING
|
+$14.3M |
| 5 |
DNMR
Danimer Scientific, Inc.
DNMR
|
+$10.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$39.1M |
| 2 |
HMSY
HMS Holdings Corp.
HMSY
|
+$35.1M |
| 3 |
RP
RealPage, Inc.
RP
|
+$28.7M |
| 4 |
EGOV
NIC Inc
EGOV
|
+$28.3M |
| 5 |
Intuit
INTU
|
+$7.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 12.72% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Discretionary | 9.92% |
Similar funds
Palisade Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Palisade Capital Management held 405 positions worth $4.26B, up 8.9% from $3.91B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Palisade Capital Management withdrew a net $588M in Q1 2021, closing 20 positions and reducing 69 holdings. Its most notable exit was BioTelemetry, Inc., an estimated $39.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Palisade Capital Management opened a new position in AdaptHealth worth $23.7M.
- Palisade Capital Management's largest Q1 2021 buy was AdaptHealth: 644,242 shares worth $23.7M.
- Palisade Capital Management added most to Ping Identity Holding Corp. in Q1 2021, an estimated $14.3M increase.
- Palisade Capital Management's biggest Q1 2021 reduction was Intuit, cutting an estimated $7.31M.
- Palisade Capital Management fully exited BioTelemetry, Inc. in Q1 2021, selling an estimated $39.1M.
- Palisade Capital Management's ten largest holdings make up 14% of its $4.26B portfolio in Q1 2021.
- Palisade Capital Management opened 20 new positions and closed 20 in Q1 2021.
- Palisade Capital Management's portfolio value rose 8.9% quarter-over-quarter to $4.26B.
Based on Palisade Capital Management's 13F filing for Q1 2021, filed 12 May 2021.